Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Kuopio
AddAiraksinen, O(lavi)
AddAlhava, E.
AddAlhonen, L.
AddAtalay, M(ustafa)
AddCederberg, H.
AddDunkel, L(eo)
AddEskelinen, M(atti)
AddGiniatullin, R.
AddGröhn, O(lli)
AddHarno, K.
AddHartikainen, J(aana).
AddHartikainen, J(uha).
AddHarvima, I.
AddHiltunen, M(ikko)
AddJääskeläinen, J(uha) E.
AddJäkälä, P(ekka)
AddJänne, J.
AddJantunen, E(sa)
AddJärvinen, R.
AddJulkunen, P.
AddKaikkonen, M(inna) U.
AddKauhanen, J(ussi)
AddKivipelto, M(iia)
AddKoistinaho, M.
AddKoivisto, T(imo)
AddKokki, H.
AddKönönen, M.
AddKosma, V(eli)-M(atti)
AddKröger, H.
AddKurl, S(udhir)
AddKuusisto, J(ohanna)
AddLaakso, M(arkku)
AddLakka, T(imo) A.
AddLapinlampi, N(iina)
AddLaukkanen, J(ari) (UEF/KSSHP)
AddLevonen, A(nna)-L(iisa)
AddLindgren, A(ntti) E.
AddLöppönen, H(eikki)
AddMannermaa, A.
AddManninen, H.
AddMecklin, J(ukka)-P(ekka)
AddMoilanen, L(eena)
AddMönkkönen, J.
AddMykkänen, H.
AddNuutinen, J.
AddPaajanen, H.
AddPaananen, J.
AddPalvimo, J.J.
AddPelkonen, J(ukka)
AddPihlajamäki, J(ussi)
AddPihlajamäki, M.
AddPitkänen, A(sla)
AddPunnonen, K.
AddRaatikainen K
AddRauramaa, R.
AddRissanen, T.T.
AddRoine, R(isto) P.
AddRyynänen, O.P.
AddSaarikoski, S.
AddSchwab, U(rsula)
AddSivenius, J.
AddSoininen, H(ilkka)
AddSoininen, P(asi)
AddSorri, I.
AddStancakova, A(lena)
AddSulkava, R.
AddSund, R(eijo)
AddTammi, M.
AddTanila, H(eikki)
AddTiihonen, J(ari)
AddUusaro, A.
AddUusitupa, M.
AddVanninen, R.
AddVaskilampi, T.
AddViinamäki, H(eimo)
AddVirtanen, M(arianna)
AddVoutilainen, R(aimo)
AddVoutilainen, S(ari)
AddWahlfors, J.
AddWirth, T.
AddWong, G.
AddYlä-Herttuala, S(eppo)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.Hartikainen, J(aana).189 dayssaveRefWorks
NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli.Hartikainen, J(aana).374 dayssaveRefWorks
Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation.Hartikainen, J(aana).383 dayssaveRefWorks
Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.Hartikainen, J(aana).386 dayssaveRefWorks
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.Hartikainen, J(aana).388 dayssaveRefWorks
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.Hartikainen, J(aana).393 dayssaveRefWorks
Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C).Hartikainen, J(aana).397 dayssaveRefWorks
Impact of minimal invasive extracorporeal circulation on atrial fibrillation after coronary artery bypass surgery.Hartikainen, J(aana).404 dayssaveRefWorks
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.Hartikainen, J(aana).567 dayssaveRefWorks
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.Hartikainen, J(aana).616 dayssaveRefWorks
Clinical and epidemiological observations on individual radiation sensitivity and susceptibility.Hartikainen, J(aana).677 dayssaveRefWorks
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.Hartikainen, J(aana).704 dayssaveRefWorks
CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.Hartikainen, J(aana).855 dayssaveRefWorks
Genome-wide association study of germline variants and breast cancer-specific mortality.Hartikainen, J(aana).887 dayssaveRefWorks
Optimal timing for cardioversion in patients with atrial fibrillation.Hartikainen, J(aana).993 dayssaveRefWorks
Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.Hartikainen, J(aana).1058 dayssaveRefWorks
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.Hartikainen, J(aana).1188 dayssaveRefWorks
Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.Hartikainen, J(aana).1288 dayssaveRefWorks
Body mass index and breast cancer survival: a Mendelian randomization analysis.Hartikainen, J(aana).1324 dayssaveRefWorks
Association analysis identifies 65 new breast cancer risk loci.Hartikainen, J(aana).1374 dayssaveRefWorks
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Hartikainen, J(aana).1374 dayssaveRefWorks
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.Hartikainen, J(aana).1433 dayssaveRefWorks
Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.Hartikainen, J(aana).1442 dayssaveRefWorks
Association of objectively measured sedentary behaviour and physical activity with cardiovascular disease risk.Hartikainen, J(aana).1528 dayssaveRefWorks
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.Hartikainen, J(aana).1534 dayssaveRefWorks
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Hartikainen, J(aana).1547 dayssaveRefWorks
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.Hartikainen, J(aana).1573 dayssaveRefWorks
Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.Hartikainen, J(aana).1584 dayssaveRefWorks
Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.Hartikainen, J(aana).1591 dayssaveRefWorks
Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.Hartikainen, J(aana).1651 dayssaveRefWorks
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study.Hartikainen, J(aana).1667 dayssaveRefWorks
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).Hartikainen, J(aana).1675 dayssaveRefWorks
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation.Hartikainen, J(aana).1677 dayssaveRefWorks
Heart rate variability density analysis (Dyx) for identification of appropriate implantable cardioverter defibrillator recipients among elderly patients with acute myocardial infarction and left ventricular systolic dysfunction.Hartikainen, J(aana).1741 dayssaveRefWorks
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.Hartikainen, J(aana).1786 dayssaveRefWorks
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Hartikainen, J(aana).1823 dayssaveRefWorks
RAD51B in Familial Breast Cancer.Hartikainen, J(aana).1910 dayssaveRefWorks
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.Hartikainen, J(aana).2050 dayssaveRefWorks
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.Hartikainen, J(aana).2066 dayssaveRefWorks
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Hartikainen, J(aana).2088 dayssaveRefWorks
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.Hartikainen, J(aana).2165 dayssaveRefWorks
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.Hartikainen, J(aana).2217 dayssaveRefWorks
Common germline polymorphisms associated with breast cancer specific survival.Hartikainen, J(aana).2290 dayssaveRefWorks
Identification of novel genetic markers of breast cancer survival.Hartikainen, J(aana).2290 dayssaveRefWorks
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.Hartikainen, J(aana).2295 dayssaveRefWorks
Prediction of breast cancer risk based on profiling with common genetic variants.Hartikainen, J(aana).2302 dayssaveRefWorks
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.Hartikainen, J(aana).2304 dayssaveRefWorks
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.Hartikainen, J(aana).2310 dayssaveRefWorks
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.Hartikainen, J(aana).2333 dayssaveRefWorks
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Hartikainen, J(aana).2365 dayssaveRefWorks
 XML / RSS feed
next »